Post job

Competitor Summary. See how Medisolv compares to its main competitors:

  • Max Healthcare has the most employees (3,783).
Work at Medisolv?
Share your experience

Medisolv vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1998
3.7
Columbia, MD1$6.9M88
2005
4.2
Princeton, NJ13$200.0M40
-
3.7
Odessa, TX1$6.8M49
2001
3.7
--$260.0M3,783
2002
3.4
--$100.0M750
1996
4.3
Dallas, TX1$21.3M30
1989
3.5
Naperville, IL1$1.9M27
2014
4.2
Newport Beach, CA3$266.3M200

Rate how well Medisolv differentiates itself from its competitors.

Zippia waving zebra

Medisolv salaries vs competitors

Compare Medisolv salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Medisolv
$45,449$21.85-

Compare Medisolv job title salaries vs competitors

CompanyHighest salaryHourly salary
Medisolv
$32,169$15.47
CitiusTech
$40,329$19.39
Max Healthcare
$34,058$16.37
Phytel
$32,790$15.76
Gisystems.org (india) Private Limited
$32,453$15.60
GMC HOSPITAL
$32,251$15.51
Context 4 Healthcare
$32,079$15.42
Evolus
$32,023$15.40

Do you work at Medisolv?

Does Medisolv effectively differentiate itself from competitors?

Medisolv jobs

Medisolv demographics vs competitors

Compare gender at Medisolv vs competitors

Job titleMaleFemale
Max Healthcare55%45%
CitiusTech78%22%
Medisolv--
Male
Female
100%
75%
50%
25%
0%
0%
25%
50%
75%
100%

Compare race at Medisolv vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
46%8%7%30%8%
7.3
53%10%8%25%4%
7.1

Medisolv and similar companies CEOs

CEOBio
Bhaskar Sambasivan
CitiusTech

Steven Schelhammer
Phytel

Steve Schelhammer is Chief Executive Officer at Phytel. The 25-year healthcare veteran is responsible for the company’s strategic direction and market positioning. His expertise in disease management is evident in his previous leadership positions. Before joining Phytel, Mr. Schelhammer founded Accordant Health Services, one of the country’s first disease management companies. The company grew to providing services for more than 500,000 people affected by complex chronic diseases. In 2000, he received the Ernst & Young Regional Entrepreneur of the Year Award for his work at Accordant. He also played a pivotal role in founding the Disease Management Association of America, where he was a charter member and served on its board for the first 3 years. Before founding Accordant, Mr. Schelhammer served as senior vice president at Quantum Health Resources, providing specialized home care services to people affected by rare chronic diseases. He also held upper management positions with other alternate site healthcare organizations including Care Partners, Tokos Medical Corporation and Caremark.

David Moatazedi
Evolus

David Moatazedi is the President and Chief Executive Officer of Evolus (NASDAQ: EOLS). Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today.breakthrough products. David has nearly twenty years of commercial and executive experience building multiple market leading brands, including his most recent tenure as Senior Vice President of U.S. Medical Aesthetics at Allergan™ where he led the Medical aesthetic portfolio and several multi-billion-dollar acquisitions. David also currently sits on the board of Obalon Therapeutics (NASDAQ: OBLN). He holds an MBA in Marketing from Pepperdine University and a B.A. in Chemistry from California State University, Long Beach. David resides in Newport Beach with his wife and three children.

Mark A. Earles
Context 4 Healthcare

Medisolv competitors FAQs

Search for jobs